Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription

Articles published in Oncology

Retrieve available abstracts of 4 articles:
HTML format

Single Articles

    January 2019
  1. METZINGER MN, Verghese C, Hamouda DM, Lenhard A, et al
    Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience.
    Oncology. 2019;97:59-74.
    PubMed     Abstract available

    February 2018
  2. PUVVADA SD, Guillen-Rodriguez JM, Yan J, Inclan L, et al
    Yttrium-90-Ibritumomab Tiuxetan (Zevalin(R)) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
    Oncology. 2018 Feb 22. pii: 000486788. doi: 10.1159/000486788.
    PubMed     Abstract available

    September 2017
  3. PUVVADA SD, Guillen-Rodriguez JM, Rivera XI, Heard K, et al
    A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma.
    Oncology. 2017 Sep 5. doi: 10.1159/000479230.
    PubMed     Abstract available

    January 2017
  4. NAKAMURA A, Kojima Y, Miyazawa K, Matsumoto S, et al
    Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.
    Oncology. 2017;93:302-308.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.